About

mattia.mori@unisi.it

Mattia Mori is associate professor in medicinal chemistry at the University of Siena. Research interests span from the use of computational tools for structural studies on macromolecules of therapeutic relevance to the identification and optimization of small molecules as drug candidates.

patricia.rijo@ulusofona.pt

Patrícia Rijo is a medicinal chemist with a PhD in Pharmaceutical and Therapeutic Chemistry from the Faculty of Pharmacy of the University of Lisbon, Portugal. Currently, she is an associate professor at Lusófona University. Her research includes extraction, isolation, structural characterization, and molecular design of bioactive natural products from different natural sources, namely with antimicrobial activity.

prs@chemrsc.org

Priyanka Sahariah is a Research Scientist in Polymer Chemistry at the University of Iceland and a Development Scientist at Alvotech, Iceland. Research interests include design, synthesis and structural characterization of biopolymer based conjugates for various biomedical applications including antimicrobial activity.

danare@mail.huji.ac.il

Dana Reichmann is an Associate professor at the Department of Biological Chemistry at the Hebrew University of Jerusalem. Her research is dealing with understanding how microorganisms (yeast and bacteria) maintain their “healthy” and complex proteome during stress conditions. To achieve this goal, the Reichmann lab is utilizing and developing an extensive toolbox of technologies which are able to quantify changes on cellular and molecular levels, including in-vivo fluorescence-based sensors, and mass spectrometry based techniques such as redox and structural proteomics.

carole.devaux@lih.lu

Carole Devaux is a senior researcher at the Luxembourg Institute of Health focusing on translational research in infectious diseases. Her work spans over the development of immunoassays and in vivo models of infection to the development of immunotherapeutics against pathogens.

didem.sen.karaman@ikcu.edu.tr 

Didem ŞEN KARAMAN is an associate professor of biomedical engineering at İzmir Katip Çelebi University (İzmir, Turkey). Her research interests encompass the design of nanostructured materials as drug delivery systems, inherent antibacterial nanostructures, and the identification of their antibacterial modes of action.

shawser@ihma.com

Stephen Hawser has 30 years of anti-infective industrial experience and since 2009 is CEO of IHMA Europe Sàrl, a CRO with extensive activities and expertise in the antimicrobial resistance space (AMR).  Prior to 2009, he gained 15 years in the AMR space with Arpida (Switzerland), GlaxoWellcome (Italy), Hoechst Marion Roussel (France) and Marion Merrell Dow (Italy).  He has regularly published at scientific conferences (>850 posters), in international peer-reviewed journals (>110 articles) and is co-inventor of a number of patents and is editor / reviewer for multiple journals. His core passion is the  AMR space and in collaborating with multiple entities, groups and initiatives in combatting AMR.